Skip to main navigation Skip to search Skip to main content

Detection of the granulocyte‐specific antigen 3‐fucosyl‐N‐acetyl‐lactosamine on leukemic cells after neuraminidase treatment

  • P. A. T. Tetteroo*
  • , M. B. T. van Veer
  • , J. F. Tromp
  • , A. E. G. Kr von dem Borne
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The carbohydrate antigen 3‐fucosyl‐N‐acetyl‐lactos‐amine (FAL) is expressed on human granulocytes and is detected by a monoclonal antibody B4.3. After neuraminidase treatment, this structure can also be detected on monocytes and on the cells of nearly all acute myeloid leukemia patients (38/39). It is then also present on the cells of a number of CALLA‐positive lymphatic leukemias (8/18), but not on T‐ALL and B‐ALL cells. On cells of patients with AUL, the antigen is then detected in many TdT+ cases, but not in TdT− cases. Copyright © 1984 Wiley‐Liss, Inc., A Wiley Company
Original languageEnglish
Pages (from-to)355-358
JournalInternational Journal of Cancer
Volume33
Issue number3
DOIs
Publication statusPublished - 1984
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Detection of the granulocyte‐specific antigen 3‐fucosyl‐N‐acetyl‐lactosamine on leukemic cells after neuraminidase treatment'. Together they form a unique fingerprint.

Cite this